5-aminolaevulinic acid/photo-dynamic therapy and gefitinib in non-small cell lung cancer cell lines: a potential strategy to improve gefitinib therapeutic efficacy. (Q39123460)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 2013

Language	Label	Description	Also known as
English	5-aminolaevulinic acid/photo-dynamic therapy and gefitinib in non-small cell lung cancer cell lines: a potential strategy to improve gefitinib therapeutic efficacy.	scientific article published on August 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23869760 AND SRC:MED&resulttype=core&format=json

5 March 2020

5-aminolaevulinic acid/photo-dynamic therapy and gefitinib in non-small cell lung cancer cell lines: a potential strategy to improve gefitinib therapeutic efficacy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23869760 AND SRC:MED&resulttype=core&format=json

5 March 2020

non-small-cell lung carcinoma

1 reference

based on heuristic

inferred from title

Giuseppe Palumbo

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6622218&resulttype=core&format=json

15 May 2020

author name string

I Postiglione

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6622218&resulttype=core&format=json

15 May 2020

A Chiaviello

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6622218&resulttype=core&format=json

15 May 2020

S M Aloj

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6622218&resulttype=core&format=json

15 May 2020

publication date

1 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23869760 AND SRC:MED&resulttype=core&format=json

5 March 2020

Cell Proliferation

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6622218&resulttype=core&format=json

15 May 2020

46

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6622218&resulttype=core&format=json

15 May 2020

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6622218&resulttype=core&format=json

15 May 2020

382-395

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6622218&resulttype=core&format=json

15 May 2020

Adjuvant Chemotherapy for Early-Stage Non-small Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

ErbB-targeted therapeutic approaches in human cancer

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

Molecular predictors of EGFR-TKI sensitivity in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

Inhibitors of epidermal-growth-factor receptors: a review of clinical research with a focus on non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

The epidermal growth factor receptor and its inhibition in cancer therapy

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib.

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

Photodynamic therapy for cancer

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

A phase-1 study of sequential mitomycin C and 5-aminolaevulinic acid-mediated photodynamic therapy in recurrent superficial bladder carcinoma.

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

Photodynamic therapy for lung cancer — A review of 19 years' experience

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

Combination of photodynamic therapy with anti-cancer agents

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

5-Aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

Quantitative studies of the kinetics of 5-aminolaevulinic acid-induced fluorescence in bladder transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

Mutation of epidermal growth factor receptor is associated with MIG6 expression

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255.

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

A biomarker that identifies senescent human cells in culture and in aging skin in vivo

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

Combination of photodynamic therapy with aspirin in human-derived lung adenocarcinoma cells affects proteasome activity and induces apoptosis.

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

How to monitor NF-kappaB activation after photodynamic therapy

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

In vitro resistance of articular chondrocytes to 5-Aminolevulinic acid based photodynamic therapy.

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

p53 enhances gefitinib-induced growth inhibition and apoptosis by regulation of Fas in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

Molecular mechanisms of ZD1839-induced G1-cell cycle arrest and apoptosis in human lung adenocarcinoma A549 cells

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

Constitutive and inducible nuclear factor-kappaB in immortalized normal human bronchial epithelial and non-small cell lung cancer cell lines.

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

Mitochondria and cell death: outer membrane permeabilization and beyond

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

The role of apoptosis in response to photodynamic therapy: what, where, why, and how.

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

EGFR tyrosine kinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

Autophagy promotes necrosis in apoptosis-deficient cells in response to ER stress

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

An epidermal growth factor inhibitor, Gefitinib, induces apoptosis through a p53-dependent upregulation of pro-apoptotic molecules and downregulation of anti-apoptotic molecules in human lung adenocarcinoma A549 cells

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

NF-kappaB in lung tumorigenesis

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

Epidermal growth factor receptor inhibition sensitizes renal cell carcinoma cells to the cytotoxic effects of bortezomib.

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

Gefitinib enhances the efficacy of photodynamic therapy using 5-aminolevulinic acid in malignant brain tumor cells

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

ABCG2: the key to chemoresistance in cancer stem cells?

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

C421 allele-specific ABCG2 gene amplification confers resistance to the antitumor triazoloacridone C-1305 in human lung cancer cells.

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

Acquisition of an enhanced aggressive phenotype in human lung cancer cells selected by suboptimal doses of cisplatin following cell deattachment and reattachment.

1 reference

https://api.crossref.org/works/10.1111/CPR.12040

21 January 2018

Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23869760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges

1 reference

https://pubmed.ncbi.nlm.nih.gov/23869760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A study comparing endogenous protoporphyrin IX induced by 5-ALA and ALA-methyl ester with exogenous PpIX and PpIX dimethyl ester in photodynamic diagnosis of human nasopharyngeal carcinoma xenografts

1 reference

https://pubmed.ncbi.nlm.nih.gov/23869760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Photodynamic therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23869760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibodies to target epidermal growth factor receptor-positive tumors: a new paradigm for cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23869760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23869760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response to epidermal growth factor receptor inhibitors in non-small cell lung cancer cells: limited antiproliferative effects and absence of apoptosis associated with persistent activity of extracellular signal-regulated kinase or Akt kinase pathwa

1 reference

https://pubmed.ncbi.nlm.nih.gov/23869760

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/CPR.12040

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6622218&resulttype=core&format=json

15 May 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6622218&resulttype=core&format=json

15 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6622218&resulttype=core&format=json

15 May 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39123460&oldid=1515662668"